$ORGO
Organogenesis Holdings Inc. Stock $orgo

$orgo Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023005585 Filed on March 01, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$107.6M	$115.5M	$450.9M
YoY Change	9.71%	-10.14%	-3.67%
Cost Of Revenue	$26.61M	$27.11M	$105.0M
YoY Change	6.09%	-16.83%	-8.04%
Gross Profit	$81.04M	$88.41M	$345.9M
YoY Change	10.95%	-7.87%	-2.26%
Gross Profit Margin	75.28%	76.53%	76.71%
Selling, General & Admin	$73.83M	$68.29M	$283.8M
YoY Change	16.13%	1.55%	13.43%
% of Gross Profit	91.11%	77.25%	82.06%
Research & Development	$11.20M	$11.40M	$39.76M
YoY Change	30.45%	37.95%	29.34%
% of Gross Profit	13.82%	12.89%	11.5%
Depreciation & Amortization	$2.694M	$2.735M	$5.845M
YoY Change	4.91%	-8.65%	-45.53%
% of Gross Profit	3.32%	3.09%	1.69%
Operating Expenses	$85.04M	$79.69M	$323.6M
YoY Change	17.84%	5.53%	15.17%
Operating Profit	-$4.001M	$8.718M	$22.30M
YoY Change	-558.83%	-57.37%	-69.41%
Interest Expense	$649.0K	$30.00K	$2.009M
YoY Change	-188.06%	-103.52%	-127.76%
% of Operating Profit		0.34%	9.01%
Other Income/Expense, Net	-$626.0K	$6.000K	-$2.022M
YoY Change	20766.67%	-166.67%	15453.85%
Pretax Income	-$4.627M	$8.754M	$20.28M
YoY Change	-3605.3%	-55.31%	-68.2%
Income Tax	-$1.658M	$1.268M	$4.750M
% Of Pretax Income		14.48%	23.42%
Net Earnings	-$2.969M	$7.486M	$15.53M
YoY Change	-3512.64%	-85.52%	-83.63%
Net Earnings / Revenue	-2.76%	6.48%	3.44%
Basic Earnings Per Share	-$0.02		$0.12
Diluted Earnings Per Share	-$0.02	$0.06	$0.12
COMMON SHARES
Basic Shares Outstanding	131.2M	130.9M	130.1M
Diluted Shares Outstanding	131.1M		132.4M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$88.69M	$102.5M	$102.5M
YoY Change	-17.8%	-10.05%	-10.05%
Cash & Equivalents	$88.69M	$102.5M
Short-Term Investments
Other Short-Term Assets	$10.57M	$5.898M	$5.898M
YoY Change	36.54%	5.93%	5.93%
Inventory	$25.54M	$24.78M	$24.78M
Prepaid Expenses	$9.847M	$5.086M
Receivables	$92.02M	$89.45M	$89.45M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$216.8M	$222.6M	$222.6M
YoY Change	-0.47%	-1.93%	-1.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$106.6M	$102.5M	$145.7M
YoY Change	-19.05%	-20.14%	13.52%
Goodwill	$28.77M	$28.77M
YoY Change		0.0%
Intangibles	$19.56M	$20.79M
YoY Change		-19.02%
Long-Term Investments
YoY Change
Other Assets	$1.463M	$1.520M	$31.53M
YoY Change	-95.63%	-95.47%	-5.96%
Total Long-Term Assets	$229.3M	$226.8M	$226.8M
YoY Change	4.97%	4.84%	4.84%
TOTAL ASSETS
Total Short-Term Assets	$216.8M	$222.6M	$222.6M
Total Long-Term Assets	$229.3M	$226.8M	$226.8M
Total Assets	$446.1M	$449.4M	$449.4M
YoY Change	2.25%	1.38%	1.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.31M	$32.33M	$32.33M
YoY Change	8.5%	10.19%	10.19%
Accrued Expenses	$28.60M	$26.45M	$38.16M
YoY Change	-35.29%	-45.33%	-21.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.009M	$4.538M	$4.538M
YoY Change	55.22%	58.89%	58.89%
Total Short-Term Liabilities	$76.08M	$75.02M	$75.02M
YoY Change	-0.93%	-8.51%	-8.51%
LONG-TERM LIABILITIES
Long-Term Debt	$64.86M	$66.23M	$66.23M
YoY Change	-7.17%	-6.41%	-6.41%
Other Long-Term Liabilities	$1.145M	$1.122M	$42.44M
YoY Change	-97.53%	-97.68%	-12.41%
Total Long-Term Liabilities	$1.145M	$1.122M	$108.7M
YoY Change	-99.02%	-99.06%	-8.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.08M	$75.02M	$75.02M
Total Long-Term Liabilities	$1.145M	$1.122M	$108.7M
Total Liabilities	$182.4M	$183.7M	$183.7M
YoY Change	-5.51%	-8.71%	-8.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.89M	-$45.30M
YoY Change	-20.83%	-25.53%
Common Stock	$312.6M	$311.0M
YoY Change		2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$263.7M	$265.7M	$265.7M
YoY Change
Total Liabilities & Shareholders Equity	$446.1M	$449.4M	$449.4M
YoY Change	2.25%	1.38%	1.38%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.969M	$7.486M	$15.53M
YoY Change	-3512.64%	-85.52%	-83.63%
Depreciation, Depletion And Amortization	$2.694M	$2.735M	$5.845M
YoY Change	4.91%	-8.65%	-45.53%
Cash From Operating Activities	-$5.077M	$7.800M	$24.86M
YoY Change	-459.82%	-56.54%	-59.89%
INVESTING ACTIVITIES
Capital Expenditures	$7.562M	$10.66M	$33.90M
YoY Change	-213.34%	-303.86%	-208.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$7.562M	-$10.66M	-$33.90M
YoY Change	13.34%	103.86%	8.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.236M	-1.875M	-2.199M
YoY Change	61.57%	104.47%	112.26%
NET CHANGE
Cash From Operating Activities	-5.077M	7.800M	24.86M
Cash From Investing Activities	-7.562M	-10.66M	-33.90M
Cash From Financing Activities	-1.236M	-1.875M	-2.199M
Net Change In Cash	-13.88M	-4.731M	-11.24M
YoY Change	130.25%	-140.08%	-137.81%
FREE CASH FLOW
Cash From Operating Activities	-$5.077M	$7.800M	$24.86M
Capital Expenditures	$7.562M	$10.66M	$33.90M
Free Cash Flow	-$12.64M	-$2.856M	-$9.039M
YoY Change	-256.37%	-112.32%	-109.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001661181
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#FinanceLeaseLiabilityCurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37906
CY2022	dei	Entity Registrant Name EntityRegistrantName	ORGANOGENESIS HOLDINGS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1329150
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	85 Dan Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Canton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02021
CY2022	dei	City Area Code CityAreaCode	781
CY2022	dei	Local Phone Number LocalPhoneNumber	575-0775
CY2022	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value
CY2022	dei	Trading Symbol TradingSymbol	ORGO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	345200000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	131176200
CY2022	dei	Auditor Firm AuditorFirmId	49
CY2022	dei	Auditor Name AuditorName	RSM US LLP
CY2022	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102478000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113929000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	812000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	599000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89450000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82460000
CY2022Q4	us-gaap	Inventory Net InventoryNet	24783000
CY2021Q4	us-gaap	Inventory Net InventoryNet	25022000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5086000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4969000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	222609000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	226979000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102463000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79160000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20789000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25673000
CY2022Q4	us-gaap	Goodwill Goodwill	28772000
CY2021Q4	us-gaap	Goodwill Goodwill	28772000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43192000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49144000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	30014000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31994000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1520000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1537000
CY2022Q4	us-gaap	Assets Assets	449359000
CY2021Q4	us-gaap	Assets Assets	443259000
CY2021Q4	orgo	Deferred Acquisition Consideration Liability Current DeferredAcquisitionConsiderationLiabilityCurrent	1436000
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4538000
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	2656000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	200000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11708000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11785000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	32330000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	29339000
CY2022Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	26447000
CY2021Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	37289000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	75023000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	82705000
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	66231000
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	70769000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	41314000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46893000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1122000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1557000
CY2022Q4	us-gaap	Liabilities Liabilities	183690000
CY2021Q4	us-gaap	Liabilities Liabilities	201924000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131647677
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	129408740
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	130919129
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128680192
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	310957000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	302155000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45301000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60833000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	265669000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	241335000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	449359000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	443259000
CY2022	us-gaap	Revenues Revenues	450893000
CY2021	us-gaap	Revenues Revenues	467359000
CY2020	us-gaap	Revenues Revenues	338298000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	105019000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	114199000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	87319000
CY2022	us-gaap	Gross Profit GrossProfit	345874000
CY2021	us-gaap	Gross Profit GrossProfit	353160000
CY2020	us-gaap	Gross Profit GrossProfit	250979000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	283808000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	250200000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	204193000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39762000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30742000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20086000
CY2022	us-gaap	Operating Expenses OperatingExpenses	323570000
CY2021	us-gaap	Operating Expenses OperatingExpenses	280942000
CY2020	us-gaap	Operating Expenses OperatingExpenses	224279000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	22304000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	72218000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	26700000
CY2022	us-gaap	Interest Expense InterestExpense	2009000
CY2021	us-gaap	Interest Expense InterestExpense	7236000
CY2020	us-gaap	Interest Expense InterestExpense	11279000
CY2020	orgo	Gain Loss On Deferred Acquisition Consideration Settlement GainLossOnDeferredAcquisitionConsiderationSettlement	2246000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1883000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8936000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	97000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2022000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9132000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20282000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63086000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17764000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4750000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31116000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	530000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15532000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	94202000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	17234000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130070231
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128331022
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107737936
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132383152
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133662659
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111360831
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	52022000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2823000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1661000
CY2020	orgo	Other Underwriting Expenses Net Of Reimbursement By Underwriters OtherUnderwritingExpensesNetOfReimbursementByUnderwriters	4647000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60082000
CY2020	us-gaap	Profit Loss ProfitLoss	17234000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	141808000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2198000
CY2021	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-737000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-3864000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	241335000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2070000
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-648000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-6552000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	265669000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2020	us-gaap	Profit Loss ProfitLoss	17234000
CY2022	us-gaap	Depreciation Depreciation	5845000
CY2021	us-gaap	Depreciation Depreciation	5781000
CY2020	us-gaap	Depreciation Depreciation	4438000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4883000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4949000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7303000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5946000
CY2022	orgo	Non Cash Interest Expense NonCashInterestExpense	434000
CY2021	orgo	Non Cash Interest Expense NonCashInterestExpense	346000
CY2020	orgo	Non Cash Interest Expense NonCashInterestExpense	236000
CY2022	orgo	Deferred Interest Expense DeferredInterestExpense	501000
CY2021	orgo	Deferred Interest Expense DeferredInterestExpense	1493000
CY2020	orgo	Deferred Interest Expense DeferredInterestExpense	2133000
CY2020	orgo	Noncash Deferred Rent Expense And Lease Incentive Obligation NoncashDeferredRentExpenseAndLeaseIncentiveObligation	1273000
CY2020	orgo	Gain Loss On Deferred Acquisition Consideration Settlement GainLossOnDeferredAcquisitionConsiderationSettlement	2246000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1980000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31976000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	112000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4482000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1407000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-201000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1781000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2999000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1183000
CY2022	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-9648000
CY2021	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-12079000
CY2020	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-3050000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	6552000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3864000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1661000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1883000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3985000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	203000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8770000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28654000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17567000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9410000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9302000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6700000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	378000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	34000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	355000
CY2022	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	7006000
CY2021	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	6156000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3260000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3847000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4102000
CY2022	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-11850000
CY2021	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	9354000
CY2020	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1443000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	72000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6065000
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-476000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5466000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33898000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31220000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17678000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24859000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	61978000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5820000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33898000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31220000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23498000
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-10000000
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-23484000
CY2021	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-60000000
CY2020	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	10000000
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	73174000
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2813000
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	938000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	64729000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5656000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2427000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2070000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2198000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2823000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	648000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	737000
CY2022	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	608000
CY2021	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	483000
CY2020	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	3517000
CY2021	orgo	Payment To Extinguish Debt PaymentToExtinguishDebt	1620000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2199000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1036000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42468000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11238000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29722000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	24436000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114528000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84806000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60370000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103290000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114528000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84806000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2649000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	5787000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	9609000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	1201000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	607000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	61000
CY2020	orgo	Reimbursement Of Offering Expenses Included In Prepaid Expenses And Other Current Assets ReimbursementOfOfferingExpensesIncludedInPrepaidExpensesAndOtherCurrentAssets	1009000
CY2020	orgo	Non Cash Or Part Non Cash Acquisition Non Cash Financial Or Equity Instrument Consideration Shares Issued NonCashOrPartNonCashAcquisitionNonCashFinancialOrEquityInstrumentConsiderationSharesIssued	7986000
CY2022	orgo	Deferred Acquisition Consideration And Earnout Liability For Business Acquisition DeferredAcquisitionConsiderationAndEarnoutLiabilityForBusinessAcquisition	828000
CY2020	orgo	Deferred Acquisition Consideration And Earnout Liability For Business Acquisition DeferredAcquisitionConsiderationAndEarnoutLiabilityForBusinessAcquisition	5218000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1928000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3750000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2391000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1350000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53793000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q1	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	34119000
CY2021Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	37289000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	78492000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	82705000
CY2022Q1	us-gaap	Liabilities Liabilities	194744000
CY2021Q4	us-gaap	Liabilities Liabilities	201924000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61746000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60833000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	241528000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	241335000
CY2022Q1	us-gaap	Revenues Revenues	97117000
CY2021	us-gaap	Revenues Revenues	467359000
CY2022Q1	us-gaap	Gross Profit GrossProfit	72037000
CY2021	us-gaap	Gross Profit GrossProfit	353160000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-128000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	72218000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-868000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63086000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-913000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	94202000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-913000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2022Q1	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-3828000
CY2021	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	9354000
CY2022Q1	us-gaap	Revenues Revenues	97117000
CY2021	us-gaap	Revenues Revenues	467359000
CY2022Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	1619000
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3663000
CY2022Q1	orgo	Puraply Revenue PuraplyRevenue	52800000
CY2021	orgo	Puraply Revenue PuraplyRevenue	198050000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the consolidated financial statements, the estimates and assumptions that management considers to be significant and that present the greatest amount of uncertainty include revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets, assessing impairment of goodwill; valuation of assets and liabilities that use unobservable inputs, and the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	812000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	599000
CY2022	orgo	Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.167%;"/> <td style="width:1.667%;"/> <td style="width:49.167%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Leasehold improvements</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Lesser of the life of the lease or the economic life of the asset</span></span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Building</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Furniture and computers</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> - </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Equipment</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> - </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> years</span></p></td> </tr> </table>
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	6654000
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3663000
CY2020	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3572000
CY2022	us-gaap	Revenues Revenues	450893000
CY2021	us-gaap	Revenues Revenues	467359000
CY2020	us-gaap	Revenues Revenues	338298000
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	95812000
CY2021	orgo	Change In Valuation Allowance ChangeInValuationAllowance	-48300000
CY2022	orgo	Emerginggrowthcompanypolicytextblock Emerginggrowthcompanypolicytextblock	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Emerging Growth Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Before December 31, 2021, the Company was an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period afforded by the JOBS Act for the implementation of new or revised accounting standards. The Company elected to use the extended transition period for complying with new or revised accounting standards (such as ASU 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Leases </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">(Topic 842)) and, as a result of this election, the Company’s financial statements prior to 2021 may not be comparable to companies that comply with public company effective dates. Effective December 31, 2021, the Company is no longer an emerging growth company.</span></p>
CY2022	orgo	Recentlyadoptedaccountingpronouncementspolicytextblock Recentlyadoptedaccountingpronouncementspolicytextblock	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 provides temporary optional expedients and exceptions to the US GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope (“ASU 2021-01”), to clarify certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting to apply to derivatives that are affected by the discounting transition. Both ASU 2020-04 and ASU 2021-01 are effective upon issuance through December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In December 2022, the Company executed an amendment to its debt agreement, replacing LIBOR with the secured overnight financing rate (“SOFR”). The Company utilized the relief provided in these ASUs. As the amendment did not affect the amount or timing of the contractual cash flows and the contemporaneous modifications to the other terms were related to the reference rate reform, the amendment was not substantial in accordance with </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">ASC 848-20-35-8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. Therefore, the amendment did not impact the Company’s consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3782000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3782000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	87613000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6362000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5153000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89450000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82460000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2669000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2999000
CY2021	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-515000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5153000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1781000
CY2022	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-572000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6362000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12282000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9023000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1022000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	991000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11479000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15008000
CY2022Q4	us-gaap	Inventory Net InventoryNet	24783000
CY2021Q4	us-gaap	Inventory Net InventoryNet	25022000
CY2022	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	9648000
CY2021	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	12079000
CY2020	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	3050000
CY2021Q4	us-gaap	Goodwill Goodwill	28772000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58523000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	37734000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	89433000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62798000
CY2022Q4	orgo	Prepaid Subscription PrepaidSubscription	4211000
CY2021Q4	orgo	Prepaid Subscription PrepaidSubscription	2745000
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	106000
CY2021Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	538000
CY2022Q4	orgo	Prepaid Deposits PrepaidDeposits	635000
CY2021Q4	orgo	Prepaid Deposits PrepaidDeposits	1216000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	54000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	358000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	80000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	112000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5086000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4969000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	99697000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57729000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102463000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79160000
CY2022	us-gaap	Depreciation Depreciation	5845000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20789000
CY2021	us-gaap	Depreciation Depreciation	5781000
CY2020	us-gaap	Depreciation Depreciation	4438000
CY2022	orgo	Sale And Donation Charges Of Equipment Related To Construction In Progress SaleAndDonationChargesOfEquipmentRelatedToConstructionInProgress	4200000
CY2022	orgo	Cancellation Fees Related To Pause Of Construction Of Manufacturing Facility CancellationFeesRelatedToPauseOfConstructionOfManufacturingFacility	632000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58523000
CY2022Q4	us-gaap	Goodwill Goodwill	28772000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32850000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25673000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4883000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4949000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	618000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4704000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4918000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3403000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3323000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3043000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2283000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3819000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20789000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17113000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26865000
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3320000
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3458000
CY2022Q4	orgo	Accrued But Unpaid Lease Obligations And Interest Current AccruedButUnpaidLeaseObligationsAndInterestCurrent	2463000
CY2021Q4	orgo	Accrued But Unpaid Lease Obligations And Interest Current AccruedButUnpaidLeaseObligationsAndInterestCurrent	3963000
CY2021Q4	orgo	Accrued Settlement Fee Current AccruedSettlementFeeCurrent	700000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2625000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1160000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	926000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1143000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26447000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37289000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	2268000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4704000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	618000
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1192000
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3168000
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	2154000
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	3168000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	618000
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18708204
CY2022	us-gaap	Restructuring Charges RestructuringCharges	2268000
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	4244000
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	13006531
CY2021Q4	orgo	Sharesreservedforissuanceforoutstandingrestrictedstockunits Sharesreservedforissuanceforoutstandingrestrictedstockunits	764871
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	1192000
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2022Q4	us-gaap	Secured Debt SecuredDebt	71250000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	74062000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	481000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	637000
CY2022Q4	orgo	Secured Debt Net SecuredDebtNet	70769000
CY2021Q4	orgo	Secured Debt Net SecuredDebtNet	73425000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4687000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5625000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6563000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	54375000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	71250000
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0
CY2022Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	5931742
CY2021Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	6596969
CY2022Q4	orgo	Sharesreservedforissuanceforoutstandingrestrictedstockunits Sharesreservedforissuanceforoutstandingrestrictedstockunits	1381500
CY2022Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	11394962
CY2021Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	5644691
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8475000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1418224
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1069658
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0192
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0083
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6DT5H
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5066
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3931
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	8.03
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	13.57
CY2022Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	7.87
CY2021Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	13.57
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.94
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.32
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6596969
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.10
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	38524000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1418224
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.03
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1864961
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	218490
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.04
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5931742
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.91
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2245000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3079121
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.58
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y1M13D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2245000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5490567
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.68
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y11M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2245000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2082000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	813000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	178000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-106000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2575000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	899000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	505000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	17000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-39000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2770000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	860000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	418000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5446000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-30506000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	109000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3466000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1470000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1980000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31976000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	112000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4750000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31116000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	530000
CY2021	orgo	Change In Valuation Allowance ChangeInValuationAllowance	-48252000
CY2022Q4	orgo	Operating Loss Carry Forwards Tax Credit Research OperatingLossCarryForwardsTaxCreditResearch	443000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9327000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	21760000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	960000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1612000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	16000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	16000
CY2022Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	5658000
CY2021Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	7556000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8849000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1453000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	676000
CY2022Q4	orgo	Deferred Tax Assets Finance Leases DeferredTaxAssetsFinanceLeases	126000
CY2021Q4	orgo	Deferred Tax Assets Finance Leases DeferredTaxAssetsFinanceLeases	632000
CY2022Q4	orgo	Deferredtaxassetsoperatingleases Deferredtaxassetsoperatingleases	13164000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2748000
CY2021Q4	orgo	Deferredtaxassetsoperatingleases Deferredtaxassetsoperatingleases	12918000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3921000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43474000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	47918000
CY2022Q4	orgo	Deferredtaxliabilitiesrightofuseassets Deferredtaxliabilitiesrightofuseassets	10724000
CY2021Q4	orgo	Deferredtaxliabilitiesrightofuseassets Deferredtaxliabilitiesrightofuseassets	12273000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-2736000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	31994000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-3651000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	30014000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.706
CY2020	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.289
CY2021	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.091
CY2020	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.048
CY2022	orgo	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	-0.016
CY2022	orgo	Effective Income Tax Rate Reconciliation Prior Period Correction Percent EffectiveIncomeTaxRateReconciliationPriorPeriodCorrectionPercent	-0.085
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.068
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.068
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.062
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.008
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.060
CY2022	orgo	Effective Income Tax Rate Reconciliation Executive Compensation Percent EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent	0.031
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2022	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.003
CY2021	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.009
CY2020	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.009
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.030
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.234
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.493
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.029
CY2022	orgo	Description Of Recognized Tax Benefits Upon Ultimate Settlement DescriptionOfRecognizedTaxBenefitsUponUltimateSettlement	The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2642000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2307000
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2870000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1612000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2123000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2618000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	206000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	153000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	111000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	186000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	664000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	606000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1632000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1612000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2123000
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	404000
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	330000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2020	us-gaap	Profit Loss ProfitLoss	17234000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130070231
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128331022
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107737936
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132383152
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133662659
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111360831
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3445191
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	994168
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1792085
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	213000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1707000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	980000
CY2022	orgo	Finance Lease Cost FinanceLeaseCost	220000
CY2021	orgo	Finance Lease Cost FinanceLeaseCost	2687000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9570000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	7066000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2951000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2869000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	5082000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	4808000
CY2022	us-gaap	Lease Cost LeaseCost	17823000
CY2021	us-gaap	Lease Cost LeaseCost	17430000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1174000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1174000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1174000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	200000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	961000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	213000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9273000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	7276000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	200000
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1427000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1350000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1350000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53793000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53793000
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y5M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M14D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M19D
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1130
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0461
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0451
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	13747000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	7366000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	7578000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	7489000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	8002000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	18613000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	62795000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9773000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	53022000
CY2022Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	150000
CY2021Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	150000
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2246000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	6601000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3092000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2731000

Files In Submission

Name	View Source	Status
orgo-20221231_cal.xml	Edgar Link	unprocessable
orgo-20221231_pre.xml	Edgar Link	unprocessable
orgo-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
orgo-20221231_def.xml	Edgar Link	unprocessable
0000950170-23-005585-index-headers.html	Edgar Link	pending
0000950170-23-005585-index.html	Edgar Link	pending
0000950170-23-005585.txt	Edgar Link	pending
R10.htm	Edgar Link	pending
0000950170-23-005585-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img153010111_0.jpg	Edgar Link	pending
img153010111_1.jpg	Edgar Link	pending
img153010111_10.jpg	Edgar Link	pending
img153010111_11.jpg	Edgar Link	pending
img153010111_12.jpg	Edgar Link	pending
img153010111_13.jpg	Edgar Link	pending
img153010111_14.jpg	Edgar Link	pending
img153010111_15.jpg	Edgar Link	pending
img153010111_16.jpg	Edgar Link	pending
img153010111_17.jpg	Edgar Link	pending
img153010111_18.jpg	Edgar Link	pending
img153010111_19.jpg	Edgar Link	pending
img153010111_2.jpg	Edgar Link	pending
img153010111_20.jpg	Edgar Link	pending
img153010111_21.jpg	Edgar Link	pending
img153010111_22.jpg	Edgar Link	pending
img153010111_23.jpg	Edgar Link	pending
img153010111_24.jpg	Edgar Link	pending
img153010111_25.jpg	Edgar Link	pending
img153010111_3.jpg	Edgar Link	pending
img153010111_4.jpg	Edgar Link	pending
img153010111_5.jpg	Edgar Link	pending
img153010111_6.jpg	Edgar Link	pending
img153010111_7.jpg	Edgar Link	pending
img153010111_8.jpg	Edgar Link	pending
img153010111_9.jpg	Edgar Link	pending
img244321886_0.jpg	Edgar Link	pending
img244321886_1.jpg	Edgar Link	pending
img244321886_2.jpg	Edgar Link	pending
img244321886_3.jpg	Edgar Link	pending
img244321886_4.jpg	Edgar Link	pending
img244321886_5.jpg	Edgar Link	pending
img244321886_6.jpg	Edgar Link	pending
img244321886_7.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgo-20221231.htm	Edgar Link	pending
orgo-20221231.xsd	Edgar Link	pending
orgo-ex10_33.htm	Edgar Link	pending
orgo-ex21_1.htm	Edgar Link	pending
orgo-ex23_1.htm	Edgar Link	pending
orgo-ex31_1.htm	Edgar Link	pending
orgo-ex31_2.htm	Edgar Link	pending
orgo-ex32_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
orgo-20221231_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGO
Organogenesis Holdings Inc. Stock $orgo

2023 Q1 Form 10-K Financial Statement

#000095017023005585 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO Organogenesis Holdings Inc. Stock $orgo

2023 Q1 Form 10-K Financial Statement

#000095017023005585 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO
Organogenesis Holdings Inc. Stock $orgo